Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy: Rasch Analysis of NSAA in DMD
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
AIM: Reliable measurement of disease progression and the effect of therapeutic interventions in Duchenne muscular dystrophy (DMD) require clinically meaningful and scientifically sound rating scales. Therefore, we need robust evidence to support such tools. The North Star Ambulatory Assessment (NSAA) is a promising, clinician-rated scale with potential uses spanning clinical practice and clinical trials. In this study, we used Rasch analysis to test its suitability in these roles as a measurement instrument. METHOD: NSAA data from 191 ambulant boys (mean age at assessment 7 y 8 mo, SD 2 y 4 mo; range 3 y 6 mo-15 y 5 mo) with a confirmed diagnosis of DMD were examined for psychometric properties including clinical meaning, targeting, response categories, model fit, reliability, dependency, stability, and raw to interval-level measurement. All analyses were performed using the Rasch Unidimensional Measurement Model. RESULTS: Overall, Rasch analysis supported the NSAA as being a reliable (high Person Separation Index of 0.91) and valid (good targeting, little misfit, no reversed thresholds) measure of ambulatory function in DMD. One item displayed misfit (lifts head, fit residual 6.9) and there was evidence for some local dependency (stand on right/left leg, climb and descend box step right/left leg, and hop on right/left leg, residual correlations >0.40), which we provide potential solutions for in future use of the NSAA. Importantly, our findings supported good clinical validity in that the hierarchy of items within the scale produced by the analyses was supported by clinical opinion, thus increasing the clinical interpretability of scale scores. INTERPRETATION: In general, Rasch analysis supported the NSAA as a psychometrically robust scale for use in DMD clinical research and trials. This study also demonstrates how Rasch analysis is a useful instrument to detect and understand the key measurement issues of rating scales.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The proof and measurement of association between two things
Spearman, C. (1904) · The American Journal of Psychology · doi:10.2307/1412159 · Cited by 8,039
Hobart, J., & Cano, S. (2009) · Health Technology Assessment · doi:10.3310/hta13120 · Cited by 621 · cited 2×
“Further detail about Rasch measurement methods are provided elsewhere.(12,16) We examined eight tests for reliable and valid measurement, which were as follows.”
MethodSelf-citationHobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70290-9 · Cited by 495 · cited 2×
“However, although traditional psychometric methods are widely used, they have important limitations for evaluating the measurement properties of rating scales.(9) These include the following: (1) the data they generate are ordinal rather than interval; (2) scores for people and samples are scale dependent; and (3) sca…”
MethodSelf-citation
Research works printed but not linked: 24
- Drousiotou, 1998, Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus, Genet Test, 2, 55, 10.1089/gte.1998.2.55 · DOI
- Bradley, 1998, Newborn screening for Duchenne muscular dystrophy, Semin Neonatol, 3, 27, 10.1016/S1084-2756(98)80146-2 · DOI
- Emery, 1991, Population frequencies of inherited neuromuscular diseases - a world survey, Neuromuscul Disord, 1, 19, 10.1016/0960-8966(91)90039-U · DOI · Paper page
- Bushby, 2010, Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, pharmacological and psychosocial management, Lancet Neurol, 9, 77, 10.1016/S1474-4422(09)70271-6 · DOI · Paper page
- Manzur, 2008, Glucocorticoid corticosteroids for Duchenne muscular dystrophy, Cochrane Database Syst Rev, 1, CD003725
- Scott, 2006, The North Star Ambulatory Assessment. Poster presented at the Annual Meeting of the British Paediatric Neurology Association, 2006, Dev Med Child Neurol, 48, 27
- Kinali, 2009, Local restoration of dystrophin expression in Duchenne muscular dystrophy: a single blind, placebo-controlled dose escalation study using morpholino antisense oligomer AVI-4658, Lancet Neurol, 8, 918, 10.1016/S1474-4422(09)70211-X · DOI · Paper page
- Shrewsbury, 2010, Current progress and preliminary results with the systematic administration trial of AVI-4658, a novel phosophorodiamidate morpholino oligomer (PMO) skipping dystrohin exon 51 in Duchenne muscular dystrophy (DMD) World Muscle Society Meeting, Kumamoto, Japan 12-16th October, 2010, Neuromuscul Disord, 20, 639, 10.1016/j.nmd.2010.07.140 · doi:10.1016/j.nmd.2010.07.140
- Cano, 2008, Watch out, watch out, the FDA are about, Dev Med Child Neurol, 50, 408, 10.1111/j.1469-8749.2008.00408.x · DOI
- Novick, 1966, The axioms and principal results of classical test theory, J Math Psychol, 3, 1, 10.1016/0022-2496(66)90002-2 · DOI · Paper page
- Wright, 1989, Observations are always ordinal: measurements, however must be interval, Arch Phys Med Rehabil, 70, 857
- Wright, 1979, Best Test Design: Rasch Measurement
- Mazzone, 2009, Reliability of the North Star Ambulatory Assessment in a multicentric setting, Neuromuscul Disord, 19, 458, 10.1016/j.nmd.2009.06.368 · DOI · Paper page
- Rasch, 1960, Probabilistic Models for Some Intelligence and Attainment Tests
- Wright, 1982, Rating Scale Analysis: Rasch Measurement
- Hobart, 2006, Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88), Brain, 129, 224, 10.1093/brain/awh675 · DOI · Paper page
- Hagquist, 2004, Is the Sense of Coherence instrument applicable on adolescents? A latent trait analysis using Rasch modelling, Pers Individ Diff, 36, 955, 10.1016/S0191-8869(03)00164-8 · DOI
- Andrich, 1989, Proceedings of the XXIVth International Congress of Psychology, 7
- Cronbach, 1951, Coefficient alpha and the internal structure of tests, Psychometrika, 16, 297, 10.1007/BF02310555 · DOI · Paper page
- RUMM Laboratory, 19972007, RUMM2020, Version 4.0 for Windows (Upgrade 4600.0109)
- Scott, 1981, Prevention of deformity in Duchenne muscular dystrophy. A prospective study of passive stretching and splintage, Physiotherapy, 67, 177
- Hyde, 2000, A randomized comparative study of two methods for controlling tendo achilles contracture in Duchenne muscular dystrophy, Neuromuscul Disord, 10, 257, 10.1016/S0960-8966(99)00135-2 · DOI
- Steffensen, 2001, Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy, Physiother Res Int, 6, 119, 10.1002/pri.221 · doi:10.1002/pri.221
- Steffensen, 2002, Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study, Dev Med Child Neurol, 44, 623, 10.1111/j.1469-8749.2002.tb00847.x · doi:10.1111/j.1469-8749.2002.tb00847.x
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Self-citationMcDonald, C. M., Campbell, C., Torricelli, R. E., Finkel, R. S., Flanigan, K. M., Goemans, N., Heydemann, P., Kaminska, A., Kirschner, J., Muntoni, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31611-2 · Cited by 452
Self-citationChildhood spinal muscular atrophy: controversies and challenges
Mercuri, E., Bertini, E., & Iannaccone, S. T. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70061-3 · Cited by 423
Ricotti, V., Ridout, D. A., Scott, E., Quinlivan, R., Robb, S. A., Manzur, A. Y., Muntoni, F., on behalf of the NorthStar Clinical Network, Manzur, A., Muntoni, F., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303902 · Cited by 263
Self-citationLudlow, L. H., Matz-Costa, C., Johnson, C., Brown, M., Besen, E., & James, J. B. (2014) · Measurement and Evaluation in Counseling and Development · doi:10.1177/0748175614522273 · Cited by 22
Metadata
- Authors
- MAYHEW, A., CANO, S., SCOTT, E., EAGLE, M., BUSHBY, K., MUNTONI, F., & ON BEHALF OF THE NORTH STAR CLINICAL NETWORK FOR PAEDIATRIC NEUROMUSCULAR DISEASE
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 2011-03-17
- Volume
- 53
- Issue
- 6
- Pages
- 535-542
- ISSN
- 0012-1622 (ISSN-L)
- OpenAlex
- W1496452409
- Cited by
- 130
- References
- 3
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1629 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy: Rasch Analysis of NSAA in DMD. https://app.cochat.ai/papers/10.1111/j.1469-8749.2011.03939.x
- The paper
- MAYHEW, A., CANO, S., SCOTT, E., EAGLE, M., BUSHBY, K., MUNTONI, F., & ON BEHALF OF THE NORTH STAR CLINICAL NETWORK FOR PAEDIATRIC NEUROMUSCULAR DISEASE. (2011). Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy: Rasch Analysis of NSAA in DMD. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.03939.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.